PMC Links for Books (Select 4859288) - PMC

Result Filters

Links from Books

Items: 17

Select item 92988171.

Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non‐interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials

Tobias Dechow, Ali Aldaoud, Timo Behlendorf, Wolfgang Knauf, Henning Eschenburg, Matthias Groschek, Richard Hansen, Ulrike Söling, Sina Grebhardt, Hans Ulrich Siebenbach, Corinne Vannier, Karin Potthoff

Eur J Haematol. 2022 Feb; 108(2): 133–144. Published online 2021 Nov 15. doi: 10.1111/ejh.13719

PMCID:: PMC9298817

Abstract Article PDF–739K

Select item 88982892.

Safety, activity, and long-term outcomes of pomalidomide in the treatment of Kaposi sarcoma among individuals with or without HIV infection

Ramya Ramaswami, Mark N Polizzotto, Kathryn Lurain, Kathleen M Wyvill, Anaida Widell, Jomy George, Priscila Goncalves, Seth M Steinberg, Denise Whitby, Thomas S Uldrick, Robert Yarchoan

Clin Cancer Res. Author manuscript; available in PMC 2022 Sep 1.

Published in final edited form as: Clin Cancer Res. 2022 Mar 1; 28(5): 840–850. doi: 10.1158/1078-0432.CCR-21-3364

PMCID:: PMC8898289

Abstract Article PDF–827K

Select item 80386133.

Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study

Evangelos Terpos, Panagiotis Repousis, Chrysavgi Lalayanni, Evdoxia Hatjiharissi, Theodora Assimakopoulou, Georgios Vassilopoulos, Anastasia Pouli, Emmanouil Spanoudakis, Eurydiki Michalis, Gerassimos Pangalis, Ioannis Ntanasis-Stathopoulos, Christos Poziopoulos, Marie-Christine Kyrtsonis, Vasiliki Pappa, Argiris Symeonidis, Christos Georgopoulos, Panagiotis M. Zikos, Maria Gavriatopoulou, Helen A. Papadaki, Magdalini Dadakaridou, Kiki Karvounis-Marolachakis, Eirini Katodritou

J Clin Med. 2021 Apr; 10(7): 1509. Published online 2021 Apr 5. doi: 10.3390/jcm10071509

PMCID:: PMC8038613

Abstract Article PDF–1.3M

Select item 79181884.

A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease

Lauren M. Curtis, Alen Ostojic, David J. Venzon, Noa G. Holtzman, Filip Pirsl, Zoya J. Kuzmina, Kristin Baird, Jeremy J. Rose, Edward W. Cowen, Jacqueline W. Mays, Sandra A. Mitchell, Laura Parsons-Wandell, Galen O. Joe, Leora E. Comis, Ann Berger, Iskra Pusic, Cody J. Peer, William D. Figg, Liang Cao, Robert Peter Gale, Frances T. Hakim, Steven Z. Pavletic

Blood. 2021 Feb 18; 137(7): 896–907. Prepublished online 2020 Sep 24. doi: 10.1182/blood.2020006892

PMCID:: PMC7918188

Abstract Article

Select item 73372675.

Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy

Takaki Kikuchi, Shigeru Kusumoto, Yasuhito Tanaka, Yoshiko Oshima, Haruna Fujinami, Tomotaka Suzuki, Haruhito Totani, Shiori Kinoshita, Yu Asao, Tomoko Narita, Asahi Ito, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida

J Clin Exp Hematop. 2020 Jun; 60(2): 51–54. Published online 2020 May 13. doi: 10.3960/jslrt.19034

PMCID:: PMC7337267

Abstract Article PDF–1.7M

Select item 71242776.

Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma

Dipenkumar Modi, Hirva Mamdani, Theresa Vettese

Am J Med Sci. 2015 Sep; 350(3): 241–242. Published online 2015 Dec 16. doi: 10.1097/MAJ.0000000000000532

PMCID:: PMC7124277

Article PDF–305K

Select item 68326417.

Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

Marina Silvia Parisi, Salvatore Leotta, Alessandra Romano, Vittorio Del Fabro, Enrica Antonia Martino, Valeria Calafiore, Rachele Giubbolini, Uros Markovic, Valerio Leotta, Mary Ann Di Giorgio, Daniele Tibullo, Francesco Di Raimondo, Concetta Conticello

J Clin Med. 2019 Oct; 8(10): 1695. Published online 2019 Oct 16. doi: 10.3390/jcm8101695

PMCID:: PMC6832641

Abstract Article PDF–3.9M

Select item 58025078.

Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan

Yutaka Tsukune, Makoto Sasaki, Takeshi Odajima, Kazutaka Sunami, Tomomi Takei, Yukiyoshi Moriuchi, Masaki Iino, Atsushi Isoda, Aya Nakaya, Tsuyoshi Muta, Takaaki Miyake, Koji Miyazaki, Takayuki Shimizu, Kei Nakajima, Aiko Igarashi, Koji Nagafuji, Taro Kurihara, Tomonori Aoyama, Hiroki Sugimori, Norio Komatsu

Blood Cancer J. 2017 Dec; 7(12): 631. Published online 2017 Nov 23. doi: 10.1038/s41408-017-0002-2

PMCID:: PMC5802507

Article PDF–300K

Select item 49791919.

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

Ayalew Tefferi, Srdan Verstovsek, Giovanni Barosi, Francesco Passamonti, Gail J. Roboz, Heinz Gisslinger, Ronald L. Paquette, Francisco Cervantes, Candido E. Rivera, H. Joachim Deeg, Juergen Thiele, Hans M. Kvasnicka, James W. Vardiman, Yanming Zhang, B. Nebiyou Bekele, Ruben A. Mesa, Robert P. Gale, Hagop M. Kantarjian

J Clin Oncol. 2009 Sep 20; 27(27): 4563–4569. Published online 2009 Aug 3. doi: 10.1200/JCO.2008.21.7356

PMCID:: PMC4979191

Abstract Article PDF–98K

Select item 444623510.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 442714711.

Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature

Sophia Danhof, Martin Schreder, Susanne Strifler, Hermann Einsele, Stefan Knop

Case Rep Oncol. 2015 Jan-Apr; 8(1): 189–195. Published online 2015 Apr 17. doi: 10.1159/000381983

PMCID:: PMC4427147

Abstract Article PDF–621K

Select item 412332412.

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

Paul G. Richardson, David Siegel, Rachid Baz, Susan L. Kelley, Nikhil C. Munshi, Jacob Laubach, Daniel Sullivan, Melissa Alsina, Robert Schlossman, Irene M. Ghobrial, Deborah Doss, Nora Loughney, Laura McBride, Elizabeth Bilotti, Palka Anand, Lisa Nardelli, Sandra Wear, Gail Larkins, Min Chen, Mohamad H. Zaki, Christian Jacques, Kenneth C. Anderson

Blood. 2013 Mar 14; 121(11): 1961–1967. Prepublished online 2012 Dec 14. doi: 10.1182/blood-2012-08-450742

PMCID:: PMC4123324

Abstract Article

Select item 399225013.

Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study

Adrian Reuben, David G. Koch, William M. Lee, the Acute Liver Failure Study Group

Hepatology. Author manuscript; available in PMC 2014 Apr 20.

Published in final edited form as: Hepatology. 2010 Dec; 52(6): 2065–2076. Published online 2010 Oct 14. doi: 10.1002/hep.23937

PMCID:: PMC3992250

Abstract Article PDF–328K

Select item 396216214.

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study

Paul G. Richardson, David S. Siegel, Ravi Vij, Craig C. Hofmeister, Rachid Baz, Sundar Jagannath, Christine Chen, Sagar Lonial, Andrzej Jakubowiak, Nizar Bahlis, Kevin Song, Andrew Belch, Noopur Raje, Chaim Shustik, Suzanne Lentzsch, Martha Lacy, Joseph Mikhael, Jeffrey Matous, David Vesole, Min Chen, Mohamed H. Zaki, Christian Jacques, Zhinuan Yu, Kenneth C. Anderson

Blood. 2014 Mar 20; 123(12): 1826–1832. Prepublished online 2014 Jan 13. doi: 10.1182/blood-2013-11-538835